Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Axsain 0.075% w/w Cream – PA0827/004/001
- Burinex 1mg Tablet – PA22650/001/001
- Cozatan 50mg Tablet – PA0126/167/001
- Dalacin T Topical Lotion 10mg/ml Cutaneous Emulsion – PA0822/121/001
- Gerax 0.25mg Tablet – PA0577/010/001
- Hypovase 1mg Tablet – PA0019/023/001
- Lipantil Supra 145mg Tablet – PA2010/015/003
- MST Continus Suspension 60mg Prolonged Release Granules – PA1688/004/010
- Neoclarityn 5mg Tablet – EU/1/00/161/011
- Neoclarityn 0.5mg/ml Oral Solution (100ml presentation only) – EU/1/00/161/062
- Noctamid 1mg Tablet – PA1410/009/001
- Olanzapine 7.5mg Tablet – EU/1/07/427/008-010
- Olanzapine 10mg Tablet – EU/1/07/427/11-14
- Questran 4g Powder for Oral Suspension – PA2239/005/001
- Relpax 40mg Film coated Tablet – PA0822/006/002
- Scheriproct 1mg Suppositories – PA1410/071/002
- Telmisartan 80mg Film coated Tablet – PA0126/228/003
The following shortage has been resolved and supply has resumed to the Irish market:
- Candist 4mg Tablet – PA0126/206/001
- Doxatan 4mg Prolonged Release Tablet – PA0126/202/004
- Paramax 500mg/5mg Tablet – PA0540/154/001
- Teveten Plus 600mg/12.5mg Film Coated Tablet – PA2010/018/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.